Top

Journal of Gastrointestinal Surgery

Published in:

Open Access 01-03-2009 | original article

Dendritic Cell-Associated Immune Inflammation of Cardiac Mucosa: A Possible Factor in the Formation of Barrett’s Esophagus

Authors: Yuri V. Bobryshev, Dinh Tran, Murray C. Killingsworth, Michael Buckland, Reginald V. N. Lord

Published in: Journal of Gastrointestinal Surgery | Issue 3/2009

Abstract

Background

The development of Barrett’s esophagus is poorly understood, but it has been suggested that cardiac mucosa is a precursor of intestinal type metaplasia and that inflammation of cardiac mucosa may play a role in the formation of Barrett’s esophagus. The present study was undertaken to examine the presence and distribution of immune-inflammatory cells in cardiac mucosa, specifically focusing on dendritic cells because of their importance as regulators of immune reactions.

Material and Methods

Endoscopic biopsy specimens were obtained from 12 patients with cardiac mucosa without Barrett’s esophagus or adenocarcinoma and from 21 patients with Barrett’s esophagus without dysplasia (intestinal metaplasia). According to histology, in nine of the 21 specimens with Barrett’s esophagus, areas of mucosa composed of cardiac type epithelium-lined glands were present as well. Immunohistochemical staining and electron microscopy were used to examine immune-inflammatory cells in paraffin-embedded sections.

Results

Immune-inflammatory cells, including T cells, B cells, dendritic cells, macrophages, and mast cells, were present in the connective tissue matrix that surrounded cardiac type epithelium-lined glands in all patients with cardiac mucosa. Clustering of dendritic cells with each other and with lymphocytes and the intrusion of dendritic cells between glandular mucus cells were observed. In the Barrett’s esophagus specimens that contained cardiac type glands, computerized CD83 expression quantitation revealed that there were more dendritic cells in cardiac mucosa than in intestinal metaplasia.

Conclusion

Immune-inflammatory infiltrates containing dendritic cells are consistently present in cardiac mucosa. The finding of a larger number of dendritic cells in areas of cardiac mucosa in Barrett’s esophagus biopsies suggests that the immune inflammation of cardiac mucosa might play a role in modifying the local tissue environment to promote the development of specialized intestinal type metaplasia.

Lord RVN. History and definition of Barrett’s esophagus. In Yeo CJ, Dempsey DT, Klein AS, Pemberton JH, Peters JH, eds. Shackelford’s surgery of alimentary tract, 6th ed. Philadelphia: Saunders Elsevier, 2007, pp 334–340.

DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303–321. doi:10.1097/00000658-200003000-00003.PubMedCrossRef

Der R, Tsao-Wei DD, DeMeester T et al. Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001;25:245–252. doi:10.1097/00000478-200102000-00013.PubMedCrossRef

Oberg S, Peters JH, DeMeester TR et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522–532. doi:10.1097/00000658-199710000-00013.PubMedCrossRef

Chandrasoma P. Pathophysiology of Barrett’s esophagus. Semin Thorac Cardiovasc Surg 1997;9:270–278.PubMed

Lord RV. Genetic Basis of the Barrett’s metaplasia, dysplasia, Adenocarcinoma sequence. Probl Gen Surg 2001;18:53–70. doi:10.1097/00013452-200106000-00008.CrossRef

Kerkhof M, Kusters JG, van Dekken H, Kuipers EJ, Siersema PD. Biomarkers for risk stratification of neoplastic progression in Barrett esophagus. Cell Oncol 2007;29:507–517.PubMed

Quinlan JM, Colleypriest BJ, Farrant M, Tosh D. Epithelial metaplasia and the development of cancer. Biochim Biophys Acta 2007;1776:10–21.PubMed

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436–444. doi:10.1038/nature07205.PubMedCrossRef

10.

O’Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001;85:473–483. doi:10.1054/bjoc.2001.1943.PubMedCrossRef

11.

Macarthur M, Hold GL, El-Omar EM. Inflammation and cancer. II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004;286:G515–G520. doi:10.1152/ajpgi.00475.2003.PubMedCrossRef

12.

Moons LM, Kusters JG, Bultman E et al. Barrett’s oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005;207:269–276. doi:10.1002/path.1847.PubMedCrossRef

13.

Cappello F, Rappa F, Anzalone R, La Rocca G, Zummo G. CD1a expression by Barrett’s metaplasia of gastric type may help to predict its evolution towards cancer. Br J Cancer 2005;92:888–890. doi:10.1038/sj.bjc.6602415.PubMedCrossRef

14.

Bobryshev YV, Tran D, Killingsworth MC, Buckland M, Lord RV. Dendritic cells in Barrett’s esophagus and esophageal adenocarcinoma. J Gastrointest Surg 2008;in press.

15.

Banchereau J, Steinman RM. Dendritic cells and control of immunity. Nature 1998;392:245–252. doi:10.1038/32588.PubMedCrossRef

16.

Lotze MT, Thomson AW. Dendritic cells: biology and clinical applications. 2nd ed. San Diego, CA: Academic, 2001.

17.

Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002;82:97–130.PubMed

18.

Heath WR, Belz GT, Behrens GM et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004;199:9–26. doi:10.1111/j.0105-2896.2004.00142.x.PubMedCrossRef

19.

Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419–426. doi:10.1038/nature06175.PubMedCrossRef

20.

Berchtold S, Mühl-Zürbes P, Maczek E, Golka A, Schuler G, Steinkasserer A. Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology 2002;205:231–246. doi:10.1078/0171-2985-00128.PubMedCrossRef

21.

Lechmann M, Zinser E, Golka A, Steinkasserer A. Role of CD83 in the immunomodulation of dendritic cells. Int Arch Allergy Immunol 2002;129:113–118. doi:10.1159/000065883.PubMedCrossRef

22.

Breloer M, Kretschmer B, Lüthje K et al. CD83 is a regulator of murine B cell function in vivo. Eur J Immunol 2007;37:634–648. doi:10.1002/eji.200636852.PubMedCrossRef

23.

Fujimoto Y, Tu L, Miller AS et al. CD83 expression influences CD4⁺ T cell development in the thymus. Cell 2002;108:755–767. doi:10.1016/S0092-8674(02)00673-6.PubMedCrossRef

24.

Lechmann M, Krooshoop DJ, Dudziak D et al. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 2001;194:1813–1821. doi:10.1084/jem.194.12.1813.PubMedCrossRef

25.

Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575–585. doi:10.1016/S0092-8674(00)80693-5.PubMedCrossRef

26.

Engering A, Geijtenbeek TB, van Vliet SJ et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002;168:2118–2126.PubMed

27.

Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 1998;37:799–810. doi:10.1016/S0008-6363(97)00229-0.PubMedCrossRef

28.

Bobryshev YV, Lord RSA. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch Histol Cytol 1995;58:307–322. doi:10.1679/aohc.58.307.PubMedCrossRef

29.

Takahashi K, Naito M, Shultz LD, Hayashi S, Nishikawa S. Differentiation of dendritic cell populations in macrophage colony-stimulating factor-deficient mice homozygous for the osteopetrosis (op) mutation. J Leukoc Biol 1993;53:19–28.PubMed

30.

Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005;26:1700–1704. doi:10.1093/eurheartj/ehi282.PubMedCrossRef

31.

Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK. Is Barrett’s esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997;226:725–735. doi:10.1097/00000658-199712000-00009.PubMedCrossRef

32.

Griffel L, Weston A, Karalnik N, Amenta P, Das K. Early diagnosis of short-segment Barrett’s esophagus (SSBE) using an immunohistochemical marker: an inter-institutional blinded study. Gastroenterology 1998;114:A140.

33.

Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett’s) metaplasia. Mod Pathol 2004;17:1282–1288. doi:10.1038/modpathol.3800182.PubMedCrossRef

34.

DeMeester SR, Wickramasinghe KS, Lord RV et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett’s esophagus. Am J Gastroenterol 2002;97:2514–2523. doi:10.1111/j.1572-0241.2002.06033.x.PubMedCrossRef

35.

Lord RV, Wickramasinghe K, Johansson JJ, DeMeester SR, Brabender J, DeMeester TR. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett’s-like features. Surgery 2004;136:633–640. doi:10.1016/j.surg.2004.01.009.PubMedCrossRef

36.

Goldblum JR. Barrett’s esophagus and Barrett’s-related dysplasia. Mod Pathol 2003;16:316–324. doi:10.1097/01.MP.0000062996.66432.12.PubMedCrossRef

37.

Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus 2007;20:36–41. doi:10.1111/j.1442-2050.2007.00638.x.PubMedCrossRef

38.

Shu S, Zheng R, Lee WT, Cohen PA. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol 2007;27:463–483.PubMed

39.

Fujii S. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies. Trends Immunol 2008;29:242–249. doi:10.1016/j.it.2008.02.002.PubMedCrossRef

40.

Vulink A, Radford KJ, Melief C, Hart DN. Dendritic cells in cancer immunotherapy. Adv Cancer Res 2008;99:363–407. doi:10.1016/S0065-230X(07)99006-5.PubMedCrossRef

41.

Duivenvoorde LM, van Mierlo GJ, Boonman ZF, Toes RE. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology 2006;211:627–632. doi:10.1016/j.imbio.2006.05.014.PubMedCrossRef

Title: Dendritic Cell-Associated Immune Inflammation of Cardiac Mucosa: A Possible Factor in the Formation of Barrett’s Esophagus
Authors: Yuri V. Bobryshev
Dinh Tran
Murray C. Killingsworth
Michael Buckland
Reginald V. N. Lord
Publication date: 01-03-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 3/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0746-x

2024 ASCO Annual Meeting

Springer Medicine

Dendritic Cell-Associated Immune Inflammation of Cardiac Mucosa: A Possible Factor in the Formation of Barrett’s Esophagus

Abstract

Background

Material and Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Material and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2009

Laparoscopic Esophagomyotomy for Achalasia: How I Do It

Use of Positron Emission Tomography in Surgery Follow-Up of Esophageal Cancer

Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent?

Colonic Diverticular Bleeding with Comorbid Diseases may Need Elective Colectomy

Does the Use of Nizatidine, as a Pro-kinetic Agent, Improve Gastric Emptying in Patients Post-oesophagectomy?

Totally Transumbilical Laparoscopic Cholecystectomy